
BioGaia AB (publ)
BioGaia AB (publ) (BIOGY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOGY · as of Jun 8, 2026
Key Statistics
Explore BioGaia AB (publ) Data
biogy stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
biogy competitorsStock Performance
Full HistoryAbout BioGaia AB (publ)
BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into th…
what is biogaia ab (publ) · biogy stock overview · biogaia ab (publ) company profile · who is biogaia ab (publ) ceo · biogy OTC · biogaia ab (publ) headquarters · biogaia ab (publ) business segments
About Stock Overview & Key Data
BioGaia AB (publ) (BIOGY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 8, 2021. As of the latest trading session, BIOGY stock price is $11.00, with a market capitalization of $1.1B. The stock has returned +22.49% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, BioGaia AB (publ) reported revenue of $1.5B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioGaia AB (publ) (BIOGY) stock price is $11.00. The stock is traded on OTC under the ticker symbol BIOGY. The 52-week range is $8.79 – $11.46.